Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Paderina DZ"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-5 z 5
    Tytuł:
    Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients
    Autorzy:
    Boiko AS
    Pozhidaev IV
    Paderina DZ
    Bocharova AV
    Mednova IA
    Fedorenko OY
    Kornetova EG
    Loonen AJM
    Semke AV
    Bokhan NA
    Ivanova SA
    Pokaż więcej
    Temat:
    schizophrenia
    gene polymorphism
    body weight
    waist circumference
    fat mass and obesity associated gene
    Therapeutics. Pharmacology
    RM1-950
    Źródło:
    Pharmacogenomics and Personalized Medicine, Vol Volume 14, Pp 1123-1131 (2021)
    Opis pliku:
    electronic resource
    Relacje:
    https://www.dovepress.com/search-for-possible-associations-of-fto-gene-polymorphic-variants-with-peer-reviewed-fulltext-article-PGPM; https://doaj.org/toc/1178-7066
    Dostęp URL:
    https://doaj.org/article/681ff755b9ad4ad0a2daade7eb21631a  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia.
    Autorzy:
    Fedorenko OY; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.
    Paderina DZ; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.
    Kornetova EG; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.; Department of Psychiatry, Addictology and Psychotherapy, Siberian State Medical University, 634050 Tomsk, Russia.
    Poltavskaya EG; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.
    Pozhidaev IV; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.
    Goncharova AA; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.
    Freidin MB; Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634050 Tomsk, Russia.; School of Biological and Behavioural Sciences, Queen Mary University of London, London E1 4NS, UK.
    Bocharova AV; Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634050 Tomsk, Russia.
    Bokhan NA; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.; Department of Psychiatry, Addictology and Psychotherapy, Siberian State Medical University, 634050 Tomsk, Russia.
    Loonen AJM; Unit of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands.
    Ivanova SA; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.; Department of Psychiatry, Addictology and Psychotherapy, Siberian State Medical University, 634050 Tomsk, Russia.
    Pokaż więcej
    Źródło:
    Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2022 Jun 22; Vol. 12 (7). Date of Electronic Publication: 2022 Jun 22.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design.
    Autorzy:
    Geers LM; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
    Ochi T; Pharmacotherapy, - Epidemiology & -Economics, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands.
    Vyalova NM; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation.
    Losenkov IS; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation.
    Paderina DZ; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation.; National Research Tomsk State University, Tomsk, Russian Federation.
    Pozhidaev IV; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation.; National Research Tomsk State University, Tomsk, Russian Federation.
    Simutkin GG; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation.
    Bokhan NA; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation.; National Research Tomsk State University, Tomsk, Russian Federation.; Siberian State Medical University, Tomsk, Russian Federation.
    Wilffert B; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Pharmacotherapy, - Epidemiology & -Economics, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands.
    Touw DJ; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pharmaceutical Analysis, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands.
    Loonen AJM; Pharmacotherapy, - Epidemiology & -Economics, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands.
    Ivanova SA; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation.; Siberian State Medical University, Tomsk, Russian Federation.; National Research Tomsk Polytechnic University, Tomsk, Russian Federation.
    Pokaż więcej
    Źródło:
    Human psychopharmacology [Hum Psychopharmacol] 2022 May; Vol. 37 (3), pp. e2826. Date of Electronic Publication: 2021 Nov 17.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Depressive Disorder, Major*/drug therapy
    Depressive Disorder, Major*/genetics
    ATP Binding Cassette Transporter, Subfamily B/genetics ; Antidepressive Agents/therapeutic use ; Depression ; Genotype ; Humans ; Polymorphism, Single Nucleotide/genetics ; Prospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia.
    Autorzy:
    Fedorenko OY; Mental Health Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russia.; Division for Control and Diagnostics, School of Non-Destructive Testing and Security, National Research Tomsk Polytechnic University, Tomsk, Russia.
    Paderina DZ; Mental Health Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russia.; Department of Cytology and Genetics, National Research Tomsk State University, Tomsk, Russia.
    Loonen AJM; PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.; Policy Office for Quality and Innovation of Care (BZI), GGZ Westelijk Noord-Brabant, Halsteren, The Netherlands.
    Pozhidaev IV; Mental Health Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russia.; Department of Cytology and Genetics, National Research Tomsk State University, Tomsk, Russia.
    Boiko AS; Mental Health Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russia.
    Kornetova EG; Mental Health Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russia.; Hospital, Siberian State Medical University, Tomsk, Russia.
    Bokhan NA; Mental Health Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russia.; Department of Psychotherapy and Psychological Counseling, National Research Tomsk State University, Tomsk, Russia.; Department of Psychiatry, Addictology and Psychotherapy, Siberian State Medical University, Tomsk, Russia.
    Wilffert B; PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.; Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
    Ivanova SA; Mental Health Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russia.; Division for Control and Diagnostics, School of Non-Destructive Testing and Security, National Research Tomsk Polytechnic University, Tomsk, Russia.; Department of Psychiatry, Addictology and Psychotherapy, Siberian State Medical University, Tomsk, Russia.
    Pokaż więcej
    Źródło:
    Human psychopharmacology [Hum Psychopharmacol] 2020 Jul; Vol. 35 (4), pp. e2737. Date of Electronic Publication: 2020 May 08.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antipsychotic Agents/*adverse effects
    Hyperprolactinemia/*chemically induced
    Protein Serine-Threonine Kinases/*genetics
    Schizophrenia/*drug therapy
    Adult ; Antipsychotic Agents/administration & dosage ; Female ; Gene Frequency ; Genetic Predisposition to Disease ; Genotype ; Humans ; Hyperprolactinemia/genetics ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Receptors, Dopamine D2/genetics ; Siberia
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-5 z 5

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies